Login
$CDXS
$1.07 -$0.09 (8.19%) Live

$CDXS 8-K SEC Filings

Filed On Filing
12 Nov 2026 8-K: Results of Operations and Financial Condition

Reports revenue of $19.3 million for the third quarter of 2026, company reiterates full-year revenue guidance

10 Nov 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more

[***] Certain marked information has been omitted from this exhibit because it is both not material and is the type that the Registrant treats as private or confidential.

11 Aug 2026 8-K: Results of Operations and Financial Condition

Reports revenue of $14.9 million for the second quarter of 2026, company reiterates full-year financial guidance

27 Jul 2026 8-K: Other Events

Introductory. Codexis, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 16,666,667 shares of its common stock, par value $0.0001...

23 Jul 2026 8-K: Results of Operations and Financial Condition; Other Events

On July 23, 2026, Codexis, Inc. (the “Company”) disclosed that it expects to report total revenue for the three months ended June 30, 2026 to be at least $14.8 million, and cash, cash equivalents and short-term investments as of June 30,...

22 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

Codexis, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on June 17, 2026. The following is a brief description of each matter voted upon at the Annual Meeting. A more complete description of each...

07 May 2026 8-K: Results of Operations and Financial Condition

Reports revenue of $15.2 million for the first quarter, company reiterates full-year financial guidance

14 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 8, 2026, Dennis Wolf notified the Board of Directors (the “Board”) of Codexis, Inc. (the “Company”) of his decision to resign from the Board, effective immediately. In connection with his resignation from the Board, Mr. Wolf als...

11 Mar 2026 8-K: Results of Operations and Financial Condition

Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025

06 Nov 2025 8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +1 more

Announces signing of $37.8m Supply Assurance Agreement with Merck

13 Aug 2025 8-K: Results of Operations and Financial Condition

Announces revenue of $15.3M vs $14.1M analyst consensus estimate

11 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

14 May 2025 8-K: Results of Operations and Financial Condition

Secured first revenue-generating contract for ECO Synthesis™ manufacturing services

09 Apr 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

REDWOOD CITY, Calif., April 9, 2025 — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that Byron Dorgan will retire from the Company’s Board o...

31 Mar 2025 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

27 Feb 2025 8-K: Results of Operations and Financial Condition

Total revenue of $59.3 million for the fiscal year ended December 31, 2024

16 Jan 2025 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

12 Nov 2024 8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year

The registered office of Codexis, Inc. (the “Corporation”) shall be fixed in the Corporation’s certificate of incorporation, as the same may be amended from time to time.

31 Oct 2024 8-K: Results of Operations and Financial Condition

Quarter Highlights Include Key Additions to Management Team and Extension of Cash Runway into 2027 with $31M Raise via ATM Facility

22 Oct 2024 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support